Skip to main content
. 2023 Jun 2;34:101709. doi: 10.1016/j.tranon.2023.101709

Table 6.

Adverse cardiovascular events based on type of established CVD in COVID-19 patients with cancer.

Baseline Total
N
VTE
n (%)
MI
n (%)
AF
n (%)
VF
n (%)
CMP
n (%)
HF
n (%)
CVA
n (%)
Hypotension
n (%)
CAD
Yes 1242 38 (3) 47 (4) 121 (10) 10 (1) 22 (2) 78 (6) 17 (1) 198 (16)
No 954 63 (7) 22 (3) 102 (11) 4* (0) 10 (1) 110 (1) 26 (23) 158 (17)
PAD
Yes 290 13 (4) 7 (2) 28 (10) 1* (0) 4* (1) 15 (5) 3* (1) 62 (21)
No 1906 88 (5) 62 (3) 195 (10) 13 (1) 28 (1) 173 (9) 40 (2) 294 (15)
CVA
Yes 538 23 (4) 13 (2) 50 (9) 4* (1) 5* (1) 35 (7) 25 (5) 99 (18)
No 1658 78 (5) 56 (3) 173 (10) 10 (1) 27 (2) 153 (9) 18 (1) 257 (16)
HF
Yes 783 38 (5) 27 (3) 111 (14) 9 (1) 14 (2) 146 (19) 11 (1) 140 (18)
No 1413 63 (4) 42 (3) 112 (8) 5* (0) 18 (1) 42 (3) 32 (2) 216 (15)

Cells with counts 1–4 are masked to minimize the risk of re-identification.

Abbreviations: AF = atrial fibrillation, CAD = coronary artery disease, CMP = cardiomyopathy, CVA = cerebrovascular accident, CVD = cardiovascular disease, HF = heart failure, MI = myocardial infarction, PAD = peripheral arterial disease, VF = ventricular fibrillation, VTE = venous thromboembolism.